Apple Watch blood sugar monitoring has been the tech industry’s most persistent vaporware promise. For over 15 years, Apple has chased non-invasive glucose detection, dangling the feature in front of diabetics and pre-diabetics as an inevitable Watch capability. Every September, rumors resurface. Every launch, they evaporate. But optical spectroscopy breakthroughs suggest the cycle might finally break in 2027—though Mark Gurman’s assessment that the technology remains “many years away” should temper enthusiasm.
Key Takeaways
- Optical spectroscopy using lasers can measure blood glucose non-invasively, advancing Apple’s 15-year quest.
- Analyst Jeff Pu predicts Apple Watch Series 13 (2027) as the first model with native blood sugar monitoring.
- Apple’s prototype uses a silicon photonics chip but was too large for a Watch as of 2023.
- Current Apple Watch users can view glucose via Dexcom G7 sensor integration over Bluetooth, not native measurement.
- Samsung is rumored to develop similar non-invasive monitoring for Galaxy Watch.
Why optical spectroscopy matters for Apple Watch blood sugar monitoring
Light-based glucose detection represents a genuine technical breakthrough. Apple’s approach uses optical absorption spectroscopy—a laser shines light under the skin to measure glucose concentration without requiring a needle or external sensor. This is not incremental tweaking of existing tech. It is a fundamentally different pathway to the problem Apple has pursued since the Steve Jobs era.
The challenge is miniaturization. Apple’s 2023 proof-of-concept prototype was functional but too large to fit inside a Watch. The company’s Exploratory Design Group, staffed with hundreds of engineers, continues working on scaling the silicon photonics chip down to wearable dimensions. This is why Gurman’s caution matters—the gap between “works in a lab” and “works on your wrist” is where countless health features have died.
The 2027 Series 13 prediction: credible or hype?
Analyst Jeff Pu has forecast that Apple Watch Series 13, expected in 2027, will debut with blood sugar monitoring, possibly under a product name like “Apple Watch featuring Blood Monitoring”. This timing aligns with Apple’s historical product cycles and the maturation timeline for optical spectroscopy miniaturization.
But Pu’s accuracy on Apple predictions is mixed. Past forecasts have overestimated feature arrival dates and misread supply chain signals. The 2027 claim should be treated as an educated guess, not a guarantee. Even if the technology works by then, regulatory approval for glucose monitoring—especially for non-diabetic users tracking pre-diabetes risk—introduces unpredictable delays.
Current alternatives: Dexcom G7 and the gap it fills
Today, Apple Watch owners cannot natively measure blood glucose. Instead, they rely on Dexcom G7, a continuous glucose monitor (CGM) that connects to the Watch via direct Bluetooth, allowing users to view readings on their wrist without carrying their iPhone. Dexcom has dominated the CGM market for 20 years, and the Apple Watch integration is seamless for existing users.
But Dexcom G7 requires a physical sensor worn on the body—typically on the abdomen or arm—that needs replacement every 10 days. Apple Watch blood sugar monitoring, if it works, eliminates this friction entirely. You would not need a separate device. You would not need to schedule sensor changes. That is the genuine value proposition driving Apple’s persistence.
Samsung is rumored to be developing similar non-invasive technology for future Galaxy Watch models, suggesting the entire wearables industry recognizes this as a critical missing feature.
Why 15 years of failure matters
Apple began pursuing non-invasive glucose monitoring during the Steve Jobs era, aiming to detect pre-diabetes in otherwise healthy users. Rumors peaked in 2021, when the Apple Watch Series 7 was expected to include the feature. It did not. 2024 reports noted Apple testing apps for health studies, but these were research tools, not consumer features. Every year brings fresh speculation. Every launch disappoints.
This pattern reflects the genuine difficulty of the engineering problem. Optical spectroscopy works in controlled environments. Deploying it on a wrist—where skin tone, tattoos, hair, movement, and ambient light all interfere with measurements—is exponentially harder. Apple’s silence on the feature across multiple product cycles signals that miniaturization remains unsolved, not that the company abandoned the project.
Will optical spectroscopy actually work on a Watch?
Optical spectroscopy’s core advantage is non-invasiveness. A laser shines light through skin, measuring how glucose absorbs that light at specific wavelengths. No blood sample. No sensor. No daily maintenance. The physics is sound. The engineering is the bottleneck.
Apple’s silicon photonics chip approach is sophisticated—it integrates the laser, optical components, and sensors onto a single chip. But fitting this into a Watch form factor while maintaining accuracy and battery life remains unproven at scale. A device that drains the Watch battery in four hours, or that requires recalibration weekly, would fail in the market regardless of how clever the technology is.
What about breath-based alternatives?
Competing approaches have emerged. PreEv, a clip-on breath analysis device announced in January 2025, claims to estimate glucose from breath analysis in pendant form. Isaac, another breath-based system, offers a similar approach but requires clinical validation before consumer deployment. Both are niche solutions—neither offers the seamless integration Apple is pursuing.
These alternatives highlight why Apple’s approach matters. A dedicated pendant or clip-on device adds friction. Apple Watch blood sugar monitoring would be invisible to the user—just another health metric alongside heart rate and blood oxygen. That frictionless experience is what drives adoption.
FAQ
When will Apple Watch blood sugar monitoring actually launch?
Analyst Jeff Pu predicts Apple Watch Series 13 in 2027, but this is not confirmed by Apple. Mark Gurman stated the feature is “many years away,” suggesting uncertainty even internally. Treat 2027 as a possibility, not a promise.
Can my Apple Watch measure blood sugar right now?
No. Current Apple Watches cannot directly measure glucose. You can view readings from a Dexcom G7 sensor on your Watch via Bluetooth, but this requires wearing a separate physical sensor on your body.
Is optical spectroscopy glucose monitoring accurate enough for medical use?
Apple’s prototype demonstrated proof-of-concept functionality, but no published accuracy data exists for wearable deployment. Non-medical-grade monitoring poses risks for diabetes management, so any consumer version would likely target pre-diabetes screening rather than active diabetes care.
Apple Watch blood sugar monitoring represents the collision of genuine engineering progress and persistent hype. Optical spectroscopy works. Apple has the resources and talent to miniaturize it. But 15 years of broken promises mean skepticism is earned. 2027 may be the year Apple finally delivers—or it may be the year we hear the same rumor again.
Where to Buy
This article was written with AI assistance and editorially reviewed.
Source: T3
